BELLUS Health (BLUSF) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free BLUSF Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 29, 2024 | msn.comWatercolor Blush Is The Most Natural Technique For Rosy CheeksApril 27, 2024 | yahoo.comMichelle Pfeiffer Reveals Her "All Time" Favorite Creamy BlushApril 15, 2024 | msn.comThis Viral Powder Blush Will Make You Give Up Your CreamsApril 13, 2024 | yahoo.comIf You Only Use 1 Blush for the Rest of Your Life, It Should Be This Powder-Cream DuoNovember 8, 2023 | morningstar.comNatura &Co Holding SA ADR NTCOOctober 24, 2023 | health.usnews.comRaymond R. BlushJune 16, 2023 | benzinga.comBELLUS Health Inc. Announces Voting Results from Special Meeting of ShareholdersMay 12, 2023 | msn.comBELLUS Health: Q1 Earnings InsightsApril 19, 2023 | markets.businessinsider.comWhere BELLUS Health Stands With AnalystsApril 18, 2023 | msn.comGSK to Buy Bellus for $2 Billion to Gain Cough MedicineApril 5, 2023 | seekingalpha.comBellus Health posts proof-of-concept data for cough candidateApril 5, 2023 | markets.businessinsider.comBELLUS: Phase 1 Study Establishes Proof Of Concept For Developing ER Formulation Of CamlipixantApril 5, 2023 | markets.businessinsider.comBELLUS: Phase 1 Study Establishes Proof Of Concept For Developing ER Formulation Of CamlipixantNovember 14, 2022 | benzinga.comBELLUS Health Reports Third Quarter 2022 Financial Results and Business HighlightsNovember 14, 2022 | msn.comBellus Health (BLU) Reports Q3 Loss, Misses Revenue EstimatesOctober 10, 2022 | yahoo.comBELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual MeetingJuly 18, 2022 | benzinga.comBELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United StatesMarch 10, 2022 | gurufocus.comPower Corp of Canada Buys BELLUS Health Inc, Sells Alibaba Group Holding, New Oriental ...February 17, 2022 | gurufocus.comFirst Light Asset Management, LLC Buys AtriCure Inc, Keros Therapeutics Inc, BELLUS Health Inc, ...September 13, 2021 | benzinga.comWhat's Going On With BELLUS Health's Stock Today? Get BELLUS Health News Delivered to You Automatically Sign up to receive the latest news and ratings for BLUSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. BLUSF Media Mentions By Week BLUSF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLUSF News Sentiment▼0.000.80▲Average Medical News Sentiment BLUSF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLUSF Articles This Week▼00▲BLUSF Articles Average Week Get BELLUS Health News Delivered to You Automatically Sign up to receive the latest news and ratings for BLUSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vericel News Bausch Health Companies News agilon health News Indivior News Green Thumb Industries News Celldex Therapeutics News Fortrea News Immunocore News Intellia Therapeutics News NovoCure News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BLUSF) was last updated on 5/26/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsBill Gates is all about this tiny $2 stockTimothy SykesNew Options need New Trading StrategiesNetpicksWrite this ticker symbol down…StocksToTradeThe only AI company to buyPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BELLUS Health Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
